|
长链非编码RNA RUNX1-IT1在恶性肿瘤中的研究进展
|
Abstract:
长链非编码RNA在调节基因表达水平上发挥重要的作用,广泛参与人类疾病的进展。LncRNA RUNX1-IT1被发现在多种疾病中处于失调状态,如肝细胞癌、结直肠癌、肺癌及子宫内膜癌等。本综述总结近些年LncRNA RUNX1-IT1相关研究,试图揭示其在疾病中的进展机制,为进一步研究提供参考。
Long non-coding RNAs (lncRNAs) play a pivotal role in the modulation of gene expression levels, exerting a profound influence on the progression of human diseases. LncRNA RUNX1-IT1 has been observed to be dysregulated in various pathological conditions, including hepatocellular carcinoma, colorectal cancer, lung cancer, and endometrial carcinoma, among others. This comprehensive re-view aims to synthesize recent research pertaining to LncRNA RUNX1-IT1, endeavoring to elucidate its mechanistic contributions to disease progression, thus offering valuable insights for future in-vestigations.
[1] | Chen, S.P., Zhu, G.Q., Xing, X.X., et al. (2022) LncRNA USP2-AS1 Promotes Hepatocellular Carcinoma Growth by Enhancing YBX1-Mediated HIF1α Protein Translation under Hypoxia. Frontiers in Oncology, 12, Article 882372.
https://doi.org/10.3389/fonc.2022.882372 |
[2] | Long, F., Lin, Z., Li, L., et al. (2021) Comprehensive Landscape and Future Perspectives of Circular RNAs in Colorectal Cancer. Molecular Cancer, 20, Article No. 26. https://doi.org/10.1186/s12943-021-01318-6 |
[3] | Tan, Y.T., Lin, J.F., Li, T., et al. (2021) LncRNA-Mediated Posttranslational Modifications and Reprogramming of Energy Metabolism in Cancer. Cancer Communications, 41, 109-120. https://doi.org/10.1002/cac2.12108 |
[4] | Zhu, P., Wang, Y., Wu, J., et al. (2016) LncBRM Initiates YAP1 Signalling Activation to Drive Self-Renewal of Liver Cancer Stem Cells. Nature Communications, 7, Article No. 13608. https://doi.org/10.1038/ncomms13608 |
[5] | 超陈, 吴平平, 刘钱伟, 等. 长链非编码RNA MAPKAPK5-AS1在恶性肿瘤及其他疾病中的研究进展[J]. 临床医学进展, 2022, 12(11): 10241-10248. |
[6] | Xin, C., Huang, B., Chen, M., et al. (2022) Construction and Validation of an Immune-Related LncRNA Prognostic Model for Hepatocellular Car-cinoma. Cytokine, 156, Article ID: 155923. https://doi.org/10.1016/j.cyto.2022.155923 |
[7] | Li, X. and Fu, X.D. (2019) Chromatin-Associated RNAs as Facilitators of Functional Genomic Interactions. Nature Reviews Genetics, 20, 503-519. https://doi.org/10.1038/s41576-019-0135-1 |
[8] | Liu, S., Zhang, J., Yin, L., et al. (2020) The lncRNA RUNX1-IT1 Regulates C-FOS Transcription by Interacting with RUNX1 in the Process of Pancreatic Cancer Prolifera-tion, Migration and Invasion. Cell Death & Disease, 11, Article No. 412. https://doi.org/10.1038/s41419-020-2617-7 |
[9] | Bao, L., Du, B., Guo, Y., et al. (2023) LncRNA RUNX1-IT1 Is Downregulated in Gastric Cancer and Suppresses the Maturation of miR-20a by Binding to Its Precursor. Histology & Histopathology, 38, 1321-1326. |
[10] | Jiang, X., Liu, B., Nie, Z., et al. (2021) The Role of m6A Modification in the Bio-logical Functions and Diseases. Signal Transduction and Targeted Therapy, 6, Article No. 74. https://doi.org/10.1038/s41392-020-00450-x |
[11] | Huang, D.Q., Mathurin, P., Cortez-Pinto, H. and Loomba, R. (2023) Global Epidemiology of Alcohol-Associated Cirrhosis and HCC: Trends, Projections and Risk Factors. Nature Reviews Gastroenterology & Hepatology, 20, 37-49.
https://doi.org/10.1038/s41575-022-00688-6 |
[12] | Sun, L., Wang, L., Chen, T., et al. (2020) LncRNA RUNX1-IT1 Which Is Downregulated by Hypoxia-Driven Histone Deacetylase 3 Represses Proliferation and Cancer Stem-Like Properties in Hepatocellular Carcinoma Cells. Cell Death & Disease, 11, Article No. 95. https://doi.org/10.1038/s41419-020-2274-x |
[13] | Xi, Y. and Xu, P. (2021) Global Colorectal Cancer Burden in 2020 and Projections to 2040. Translational Oncology, 14, Article ID: 101174. https://doi.org/10.1016/j.tranon.2021.101174 |
[14] | Elangovan, A., Skeans, J., Landsman, M., et al. (2021) Colorec-tal Cancer, Age, and Obesity-Related Comorbidities: A Large Database Study. Digestive Diseases and Sciences, 66, 3156-3163. https://doi.org/10.1007/s10620-020-06602-x |
[15] | Shi, J., Zhong, X., Song, Y., et al. (2019) Long Non-Coding RNA RUNX1-IT1 Plays a Tumour-Suppressive Role in Colorectal Cancer by Inhibiting Cell Proliferation and Migration. Cell Biochemistry and Function, 37, 11-20.
https://doi.org/10.1002/cbf.3368 |
[16] | Thakur, P., Seam, R.K., Gupta, M.K., et al. (2017) Breast Cancer Risk Factor Evaluation in a Western Himalayan State: A Case-Control Study and Comparison with the Western World. South Asian Journal of Cancer, 6, 106-109.
https://doi.org/10.4103/sajc.sajc_157_16 |
[17] | Wang, S., Wang, Y., Li, Q., et al. (2023) RUNX1-IT1 Favors Breast Cancer Carcinogenesis through Regulation of IGF2BP1/GPX4 Axis. Discover Oncology, 14, Article No. 42. https://doi.org/10.1007/s12672-023-00652-z |
[18] | (2020) Erratum: Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 70, 313. https://doi.org/10.3322/caac.21609 |
[19] | Klein, A.P. (2021) Pancreatic Cancer Epidemiology: Understand-ing the Role of Lifestyle and Inherited Risk Factors. Nature Reviews Gastroenterology & Hepatology, 18, 493-502. https://doi.org/10.1038/s41575-021-00457-x |
[20] | Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34.
https://doi.org/10.3322/caac.21551 |
[21] | Gray, E., Ulrich, M., Epp, A., et al. (2023) SGN-B7H4V, an Investiga-tional Vedotin ADC Directed to the Immune Checkpoint Ligand B7-H4, Shows Promising Activity in Preclinical Mod-els. Journal for ImmunoTherapy of Cancer, 11, e007572. https://doi.org/10.1136/jitc-2023-007572 |
[22] | Liang, M., Wang, H., Liu, C., Lei, T. and Min, J. (2020) LncRNA RUNX1-IT1 Is Downregulated in Endometrial Cancer and Binds to miR-21 Precursor to Suppress Its Maturation. Cancer Management and Research, 12, 13451-13459.
https://doi.org/10.2147/CMAR.S272165 |